Precision Predictions: Simcyp™ Simulator for Kinase Inhibitors
Transcript:In pharmaceutical research and development, R&D, companies utilize biosimulation and PBPK modeling technologies to identify and develop new therapeutic agents. Biosimulation technology holds immense potential for expediting FDA approvals while predicting toxicities and drug to drug interactions. Within the field of oncology, kinase inhibitor drug have shown efficacy in targeting complex diseases with over fifty … Continued
https://www.certara.com/video/precision-predictions-simcyp-simulator-for-kinase-inhibitors/